Johnson & Johnson beat earnings estimates for the fourth quarter but gave guidance for the fiscal year on the low side of expectations. J&J mentioned the medical device tax included in the Affordable Care Act several times in the company’s conference call. Johnson & Johnson outlined several ways to bring down healthcare costs and suggested focusing on one product’s costs was overlooking the bigger picture.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
